MedTrace Logo

Mental Status and Quality of Life of Post-COVID-19 Patients

NCT04949035 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 147

Last updated 2021-08-09

No results posted yet for this study

Summary

The current SARS-CoV-2 virus pandemic has already affected the lives of every person on earth. Most of the information given in the media on a daily basis focuses on the pandemic aspects. Fear of getting sick arises in the population, and once infection occurs, numerous concerns arise over the course of the disease. For some patients, hospitalization and subsequent rehabilitation is needed due to complications from the disease. Besides the aspect of treating patients physically from the disease, the psychological aspects that often accompany patients during and after the disease are not addressed. Depressive and anxiety symptoms can follow patients for many years and can affect their quality of life. Thus, the purpose of this project is to assess the mental status of patients prior to the inpatient rehabilitation program

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Assessment of mental state and quality of life

Patients qualified for rehabilitation will be assessed for stress levels as well as symptoms of anxiety and depression and quality of life before rehabilitation began

Sponsors & Collaborators

  • The Opole University of Technology

    lead OTHER

Principal Investigators

  • Joanna Szczepańska-Gieracha, Prof · University School of Physical Education, Department of Physiotherapy, Wroclaw, Poland

  • Sebastian Rutkowski, PhD · The Opole University of Technology, Opole, Poland

  • Patryk Szary, MSc · University School of Physical Education, Department of Physiotherapy, Wroclaw, Poland

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-05-28
Completion
2021-06-07

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949035 on ClinicalTrials.gov